首頁 > 市場調查報告書 > 醫療設備

疼痛

市場調查報告書

商品編碼

1297767

全球疼痛管理設備市場 - 2023-2030年

Global Pain Management Devices Market - 2023-2030

出版日期: 2023年06月15日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球疼痛管理設備市場在2022年達到37億美元，預計到2030年將見證有利可圖的成長，達到63億美元。在預測期間（2023-2030年），全球疼痛管理設備市場預計將呈現7.1%的複合成長率。

疼痛管理是醫學科學的一門學科，有助於緩解慢性疼痛患者的痛苦。眾所周知，急性疼痛有一個快速的開始作用，然而慢性疼痛可能會持續較長時間，有必要進行疼痛治療。

由於疼痛管理方面的技術進步和大規模研發的升級，對照護端測試的需求增加，以及手術後疼痛的重新出現，全球疼痛管理設備市場正在大幅成長。

市場動態

對微創手術的需求不斷成長，進一步提高了疼痛管理設備市場的成長。

在外科手術中使用的疼痛管理設備提高了病人的效果和滿意度。微創手術中最常使用的一些疼痛管理技術包括病人控制的鎮痛（PCA）泵、經皮神經電刺激（TENS）裝置和周圍神經阻滯。例如，在美國，醫療保險和醫療補助服務中心（CMS）制定了促進使用替代性疼痛管理方法的規則，以限製手術患者使用鴉片類藥物。

疼痛管理設備的可用性差

在一些低收入地區，疼痛治療設備的可用性是有限的，限制了市場成長。根據世界衛生組織的統計，55億人（佔世界人口的80%以上）無法獲得中度至重度疼痛的治療。疼痛治療的一些障礙包括對減少疼痛缺乏了解和態度，以及藥物獲取和使用方面的挑戰，特別是鴉片類藥物。

COVID-19影響分析

疼痛管理設備市場受到COVID-19的嚴重影響，其中有許多因素是背後的原因，如對基於家庭的解決方案的需求增加：由於整個流行病的運動限制和對醫療設施的有限訪問，人們更加重視基於家庭的疼痛治療。這提高了對居家疼痛治療產品的需求，如經皮神經電刺激（TENS）裝置、熱療設備和攜帶式超音波機。

遠程醫療和遠程監控：這一流行病增加了對遠程醫療和遠程監測技術的使用。虛擬諮詢和遠程監控設備已經被病人用來在家裡治療慢性疼痛疾病。具有連接功能的疼痛治療小工具越來越受歡迎，使病人能夠與醫療專家交談，並從遠處接受幫助。

Market Overview

The Global Pain Management Devices Market reached US$ 3.7 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 6.3 billion by 2030. The global pain management devices market is expected to exhibit a CAGR of 7.1% during the forecast period (2023-2030).

Pain management is a discipline of medical science that aids in the relief of chronic pain sufferers' suffering. Acute pain is known to have a fast beginning of action, however chronic pain may linger for a longer period of time, necessitating pain treatment.

The global pain management devices market is growing significantly due to escalating technological advancement and massive research and development in pain management, increasing demand for point-of-care testing, and the reappearance of pain after surgery.

Market Dynamics

The Growing Demand for Minimally Invasive Surgeries is Further Increasing the Pain Management Devices Market Growth

Pain management devices used in surgical operations increase patient results and satisfaction. Some of the most often utilized pain management technologies in minimally invasive operations include patient-controlled analgesia (PCA) pumps, transcutaneous electrical nerve stimulation (TENS) units, and peripheral nerve blocks. For instance, In United States, the Centers for Medicare and Medicaid Services (CMS) incorporated rules to promote the use of alternative pain management methods in order to limit the use of opioids for patients having surgery.

Poor Availability of Pain Management Devices

The availability of pain treatment devices is limited in several low-income locations, limiting market growth. According to WHO, 5.5 billion people (more than 80% of the world population) do not have access to moderate to severe pain remedies.2 The majority of these folks are from low- and middle-income nations. Some hurdles to pain treatment include a lack of understanding and attitudes about pain reduction, as well as challenges with drug access and use, particularly opioids.

COVID-19 Impact Analysis

Pain management devices market had severe impact by COVID-19 where numerous factors are the reason behind like Increased demand for home-based solutions: Because of movement constraints and limited access to healthcare facilities throughout the epidemic, there has been a greater emphasis on home-based pain treatment. This has raised demand for at-home pain treatment products such as transcutaneous electrical nerve stimulation (TENS) units, thermal therapy devices, and portable ultrasound machines.

Telemedicine and remote monitoring: The epidemic increased the use of telemedicine and remote monitoring technology. Virtual consultations and remote monitoring equipment have been used by patients to treat chronic pain disorders from home. Pain treatment gadgets with connection features have grown more popular, allowing patients to speak with healthcare specialists and receive help from a distance.

Segment Analysis

The global pain management devices market is segmented based on product type, application

The Musculoskeletal Pain Application Segment will be Dominated By Market Players During the Forecast Period.

During the forecast period, the musculoskeletal pain category is expected to retain a sizable proportion of 42.3%. The expanding ageing population and the increasing adoption of sedentary lifestyles are the primary causes of the rise in musculoskeletal discomfort among people. Patients and healthcare professionals are using a variety of solutions, including pain management devices, to address musculoskeletal pain, leading in segmental increase.

Geographical Analysis

North America is the Dominating Region During the Forecast Period accounting for around 39.8% of the Total Market Share

North America has dominated the market for pain treatment devices due to a huge patient pool, rising healthcare expenditure, and increased government financing and efforts.The market in the region is expanding rapidly, owing mostly to an ageing population, a drastic lifestyle connected with sickness, and neurological diseases.

For example, in 2021, an estimated 20.9% of U.S. adults (51.6 million people) had chronic pain, and 6.9% (17.1 million people) had high-impact chronic pain (i.e., chronic pain that limits daily activities significantly), with a higher prevalence among non-Hispanic American Indian or Alaska Native adults, adults who identified as bisexual, and adults who were divorced or separated.

Competitive Landscape

The major global players include: Stim Wave LLC, Baxter International, Inc., Boston Scientific Corp., ICU Medical Inc, Johnson & Johnson Company, DJO Global LLC, Liva Nova, Medtronic Plc, Smiths Medical, Abbott, and Stryker Corp.

Why Purchase the Report?

To visualize the global pain management devices market segmentation based on the product type, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global pain management devices market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global pain management devices market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increase in prevalence of pulmonary artery hypertension
- 4.1.2. Restraints
  - 4.1.2.1. Side effects of the drug used for treating Pain Management Devices
- 4.1.3. Opportunity
  - 4.1.3.1. Rapidly growing generic drug market
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion s of COVID-19

7. By Product Type

7.1 Stimulated Neuromodulator Devices
7.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
7.3 Spinal Cord Stimulation (SCS) Devices
7.4 Ablation Devices
- 7.1.1. Cryoablation Devices
- 7.1.2. Radiofrequency
7.5 Analgesia Infusion Pumps
- 7.1.3. Intrathecal Infusion Pumps
- 7.1.4. External Infusion Pumps
7.6 Others

8. By Application

8.1. Cancer Pain
8.2. Musculoskeletal Pain
8.3. Migraine
8.4. Neuropathic Pain
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. The U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. The UK
  - 9.3.5.3. France
  - 9.3.5.4. Italy
  - 9.3.5.5. Spain
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country